ArticleCardiovascular diagnosis and therapy2025
Association of bicuspid aortic valve stenosis with higher risk for hypoattenuated leaflet thickening following transcatheter aortic valve replacement.
Article in Cardiovascular diagnosis and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The association between hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve replacement (TAVR) and the risk of cerebrovascular events has attracted much attention. Although previous studies have reported that the incidence of HALT after TAVR in patients with bicuspid aortic valve (BAV) is comparable to that in patients with tricuspid aortic valve (TAV), the specific contributing factors remain incompletely understood. This study aimed to investigate the incidence, predictors, and prognosis of HALT in a TAVR cohort of young patients with 50-50% bicuspid-TAV anatomy. Methods: We retrospectively analyzed consecutive patients with severe symptomatic aortic stenosis who underwent the TAVR procedure between May 2012 and January 2021 in West China Hospital, Sichuan University. Multislice computed tomography (MSCT) was employed to evaluate the early HALT post-TAVR at discharge. Echocardiograms were conducted at baseline, upon discharge, 30 days after the procedure, and at 1-year follow-up. Patients were grouped according to the presence of HALT at discharge. The baseline data, procedural details, and clinical outcomes of the patients were compared, and then multivariate regression analysis was performed. Results: We ultimately enrolled 605 patients undergoing TAVR for severe symptomatic aortic stenosis, of whom 79 (13.1%) developed HALT during hospitalization. The incidence of HALT was significantly higher in patients with BAV than in those with TAV (15.9% Conclusions: BAV was associated with higher risk of early HALT after TAVR, whereas the presence of HALT was not associated with stroke or death at 1 year. The underlying mechanisms and long-term prognosis of HALT after TAVR in patients with BAV remain to be further investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.